HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kumiko Ogawa Selected Research

alizarin

3/2022Visualization of the distribution of anthraquinone components from madder roots in rat kidneys by desorption electrospray ionization-time-of-flight mass spectrometry imaging.
4/2014Combined application of comprehensive analysis for DNA modification and reporter gene mutation assay to evaluate kidneys of gpt delta rats given madder color or its constituents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kumiko Ogawa Research Topics

Disease

40Carcinogenesis
03/2022 - 02/2002
40Neoplasms (Cancer)
03/2022 - 02/2002
23Body Weight (Weight, Body)
12/2021 - 10/2002
11Hyperplasia
10/2022 - 03/2003
10Prostatic Neoplasms (Prostate Cancer)
02/2015 - 04/2005
9Carcinoma (Carcinomatosis)
01/2021 - 03/2003
7Adenocarcinoma
02/2015 - 02/2002
7Hepatocellular Carcinoma (Hepatoma)
09/2013 - 10/2002
6Inflammation (Inflammations)
01/2019 - 04/2003
6Neoplasm Metastasis (Metastasis)
09/2013 - 10/2002
5Hypertrophy
10/2022 - 10/2006
5Fibrosis (Cirrhosis)
01/2021 - 04/2003
4Necrosis
07/2021 - 04/2014
4Chronic Pancreatitis
04/2005 - 04/2003
3Papilloma (Papillomatosis)
01/2017 - 01/2012
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2020
2Asthma (Bronchial Asthma)
02/2021 - 01/2012
2Chromosome Aberrations (Chromosome Abnormalities)
01/2021 - 09/2013
2Infections
07/2013 - 09/2005
2Aberrant Crypt Foci
01/2011 - 06/2005
1Virus Diseases (Viral Diseases)
02/2021
1Ganglion Cysts (Ganglion)
01/2021

Drug/Important Bio-Agent (IBA)

19CarcinogensIBA
07/2021 - 10/2002
9DNA (Deoxyribonucleic Acid)IBA
01/2018 - 05/2006
7Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2021 - 10/2002
7Messenger RNA (mRNA)IBA
10/2020 - 04/2003
7AndrogensIBA
02/2015 - 04/2005
6Drinking WaterIBA
01/2017 - 10/2002
54-(methylthio)-3-butenyl isothiocyanateIBA
01/2019 - 03/2013
4Corn Oil (Oil, Corn)IBA
10/2021 - 01/2012
42- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
01/2011 - 02/2002
4N-nitrosomorpholineIBA
08/2007 - 10/2002
3ButylhydroxybutylnitrosamineIBA
01/2022 - 03/2008
3Glutathione Transferase (Glutathione S-Transferase)IBA
01/2021 - 03/2013
32-toluidine (o-toluidine)IBA
12/2020 - 01/2019
3Caspase 3 (Caspase-3)IBA
08/2017 - 11/2009
3Bromodeoxyuridine (BrdU)IBA
01/2017 - 07/2003
3phenethyl isothiocyanate (PEITC)IBA
12/2015 - 03/2003
3Proteins (Proteins, Gene)FDA Link
01/2012 - 03/2008
3nobiletinIBA
01/2011 - 12/2004
3benzocycloheptapyridineIBA
01/2011 - 02/2002
3Tumor Viral Antigens (Large T Antigen)IBA
04/2007 - 04/2005
3probasinIBA
04/2007 - 04/2005
3Transforming Growth Factor beta1 (TGF beta 1)IBA
04/2005 - 04/2003
3Lisinopril (Prinivil)FDA LinkGeneric
04/2005 - 04/2003
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2005 - 04/2003
2alizarinIBA
03/2022 - 04/2014
2Fatty Acids (Saturated Fatty Acids)IBA
02/2021 - 07/2003
2guanylyl-(3'-5')-guanosineIBA
01/2021 - 09/2014
2AcetyltransferasesIBA
01/2021 - 01/2020
2VimentinIBA
01/2021 - 03/2011
2AminesIBA
01/2021 - 01/2020
2acetamideIBA
01/2021 - 10/2020
22-anisidine (o-anisidine)IBA
01/2021 - 01/2019
2DNA AdductsIBA
01/2020 - 05/2003
2Pharmaceutical PreparationsIBA
01/2020 - 08/2017
2Ether (Diethyl Ether)IBA
03/2019 - 07/2011
2Diethylhexyl Phthalate (DEHP)IBA
01/2018 - 05/2015
2alpha-ChlorohydrinIBA
01/2017 - 07/2014
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
03/2015 - 04/2003
2Ellagic AcidIBA
02/2015 - 01/2013
2LeptinIBA
01/2014 - 01/2012
2Glutathione PeroxidaseIBA
09/2013 - 12/2007
2Alkylating AgentsIBA
06/2013 - 05/2006
2Indomethacin (Indometacin)FDA LinkGeneric
06/2012 - 10/2002
2Connexin 43 (Connexin43)IBA
05/2012 - 11/2009
2kuguacin JIBA
03/2012 - 07/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012 - 01/2004
2AntigensIBA
01/2012 - 11/2009
2ConnexinsIBA
02/2010 - 08/2007
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2008 - 04/2005
2Gap Junction beta-1 ProteinIBA
08/2007 - 01/2005
2PhytochemicalsIBA
04/2007 - 12/2004
2auraptenIBA
04/2007 - 12/2004
2Acetates (Acetic Acid Esters)FDA Link
06/2006 - 12/2004
2Angiotensin Receptor AntagonistsIBA
04/2005 - 10/2003
2candesartanIBA
04/2005 - 10/2003
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2004 - 10/2002
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2004 - 10/2002
2Dimenhydrinate (DMH)FDA LinkGeneric
07/2003 - 02/2002
21,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
07/2003 - 02/2002
1Hormones (Hormone)IBA
10/2022
1rubiadinIBA
03/2022
1lucidinIBA
03/2022
1Aldehyde DehydrogenaseIBA
01/2022
1Keratin-14 (Keratin 14)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1myrrh resin (myrrh)IBA
12/2021
1Formaldehyde (Formol)FDA Link
07/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2021
1desisobutyrylciclesonideIBA
02/2021
1ciclesonideFDA Link
02/2021
1SurvivinIBA
01/2021
11,3-dichloro-2-propanolIBA
01/2021
1von Willebrand FactorIBA
01/2021

Therapy/Procedure

5Therapeutics
12/2017 - 04/2005
4Oral Administration
04/2021 - 07/2003
4Chemoprevention
04/2016 - 02/2002
1Hepatectomy
01/2021
1Nephrectomy
01/2021